ArticleFrontiers in public health2026
Do partnered male aphrodisiac users engage in higher sexual risk behaviors related to sexually transmitted infections than single men? Evidence from a survey conducted in Kinshasa, Democratic Republic of the Congo.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drugs meant to help with erectile dysfunction are more often used for fun and to enhance sexual performance. However, the non-medical use of these medications may encourage risky sexual behavior and raise the chances of getting sexually transmitted infections, such as Human Immunodeficiency Virus. In this study, we explore the association between the aphrodisiac use and the risky sexual behavior among men aged 15-49 years in Kinshasa, Democratic Republic of the Congo. This study is a secondary analysis of data from 654 men aged 15-49 years in Kinshasa, regardless of sexual orientation. The dataset includes detailed information on socio-demographic characteristics, the use of aphrodisiac substances, and potential exposure to sexually transmitted infections. To analyze the relationship between the use of aphrodisiacs and risky sexual behavior, linear probability models were utilized. Furthermore, to assess their association with risky sexual behaviors, the study investigated the interactions between aphrodisiac use and a few factors, including marital status, and age. The main findings state that among the 654 respondents selected, 48.7% reported using aphrodisiacs in the past 12 months [95% CI: 44.95-52.61]. A linear probability model revealed that the consumption of aphrodisiacs is associated with an increased risk of engaging in risky sexual behavior [aCoef = 0.22 (95% CI: 0.17-0.28,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.